Abeona Therapeutics
Commercializes ZEVASKYN for RDEB wounds through qualified treatment centers.
$5.97
After-hours close+0.04 (+0.67%)
At close$5.93(−1.82%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$0.23 | −$0.35 | −51.1% |
| May 2026 | −$0.33 | −$0.30 | +9.1% |
| Mar 2026 | −$0.35 | −$0.34 | +2.9% |
| Nov 2025 | −$0.27 | −$0.10 | +63.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.17 | — | — | $15.8M | — | — |
| Aug 13, 2026 | −$0.23 | −$0.35 | −51.1% | $12.2M | $11.4M | −7.0% |
| May 13, 2026 | −$0.33 | −$0.30 | +9.1% | $4.6M | $8.7M | +90.7% |
| Mar 17, 2026 | −$0.35 | −$0.34 | +2.9% | $4.4M | $5.4M | +22.0% |
| Nov 12, 2025 | −$0.27 | −$0.10 | +63.0% | $5.6M | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 15, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Aug 12, 2024 | ||||||
| May 15, 2024 | ||||||
| Mar 18, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 29, 2023 | ||||||
| Nov 14, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 31, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Jul 28, 2021 | ||||||
| May 18, 2021 | ||||||
| Mar 24, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 6, 2020 | ||||||
| Mar 16, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 9, 2019 | ||||||
| May 10, 2019 | ||||||
| Mar 18, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 11, 2018 | ||||||
| Mar 16, 2018 | ||||||
| Nov 15, 2017 | ||||||
| Aug 15, 2017 | ||||||
| May 15, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 16, 2016 | ||||||
| May 16, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Nov 17, 2015 | ||||||
| Aug 14, 2015 | ||||||